RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Bayesian Capital Management, LP's Holding History (CIK: 0001632551)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024

Shares 66,900 Value ($000) $452 Avg Close $6.72 Range $5.60 - $9.55

Q2 2024

Shares 42,400 Value ($000) $318 Avg Close $8.72 Range $6.75 - $10.66

Q3 2023

Shares 59,611 Value ($000) $456 Avg Close $9.98 Range $6.44 - $16.75

Q1 2023

Shares 24,095 Value ($000) $161 Avg Close $7.93 Range $6.40 - $9.73

Q4 2022

Shares 61,395 Value ($000) $473 Avg Close $9.81 Range $7.04 - $13.29

Q1 2022

Shares 25,700 Value ($000) $184 Avg Close $10.63 Range $5.80 - $18.23

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2024	66,900	$452	$6.72	$5.60 - $9.55
Q2 2024	42,400	$318	$8.72	$6.75 - $10.66
Q3 2023	59,611	$456	$9.98	$6.44 - $16.75
Q1 2023	24,095	$161	$7.93	$6.40 - $9.73
Q4 2022	61,395	$473	$9.81	$7.04 - $13.29
Q1 2022	25,700	$184	$10.63	$5.80 - $18.23